TABLE II.
Proportion of patients on darbepoetin alfa transfused during chemotherapy
| Period | Patients transfused | |||
|---|---|---|---|---|
| Darbepoetin alfa | Placebo | |||
| (n) | (%) | (n) | (%) | |
| Week 5 to end of treatment | 31 | 27 | 77 | 52 |
| (N = 148) | (N = 149) | |||
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.